硫化供体结合物的应用在不同的疾病中
Rui Zhang1, Wumei Shi1, Xiaoyan Wu1
1College of Science, China Pharmaceutical University, Nanjing, 211198, China.
Nitric oxide : biology and chemistry
|December 11, 2024
概括
硫化 (H2S) 补充显示了与低H2S水平相关的疾病的治疗潜力. H2S供体结合物提供了一个有希望的方法,保留药物的疗效,同时减少副作用.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 硫化 (H2S) 是一种具有多种生物功能的内生气传递物.
- 在各种疾病状态中观察到降低的H2S水平,这表明H2S补充的治疗潜力.
- H2S供体结合体代表了一种新的药物开发策略.
研究的目的:
- 根据疾病应用,审查和分类H2S供体结合物.
- 突出H2S供体结合物的治疗潜力,用于治疗各种疾病.
- 为未来对H2S及其结合物的研究提供见解.
主要方法:
- 关于H2S供体结合物的研究的文献综述.
- 基于治疗领域 (炎症,心血管,中枢神经系统,癌症) 的结合物的分类.
- 对联合疗效和安全性概况的分析.
主要成果:
- H2S供体结合物可以保留原始药物的治疗活性.
- 这些合物显示出降低与传统药物相关的不良影响的潜力.
- 应用范围跨越炎症,心血管和脑血管疾病,中枢神经系统疾病和癌症.
结论:
- H2S供体结合物是有前途的候选药物,具有有效性和安全性的双重好处.
- 本综述为理解和开发基于H2S的治疗方法提供了一个框架.
- 对H2S供体结合物的进一步研究对于各种疾病管理是有必要的.
相关概念视频
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
172
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
172
Phase II Reactions: Miscellaneous Conjugation Reactions
40
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
40
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.2K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.2K
Preparation and Reactions of Sulfides
4.7K
Sulfides are the sulfur analog of ethers, just as thiols are the sulfur analog of alcohol. Like ethers, sulfides also consist of two hydrocarbon groups bonded to the central sulfur atom. Depending upon the type of groups present, sulfides can be symmetrical or asymmetrical. Symmetrical sulfides can be prepared via an SN2 reaction between 2 equivalents of an alkyl halide and one equivalent of sodium sulfide.
4.7K
Preparation and Reactions of Thiols
6.0K
Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
6.0K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
142
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
142


